A Phase 1 trial designed to examine...
A Phase 1 trial designed to examine the weights of Betaferon (Schering AG, Berlin, Germany) and Rebif (Serono, Geneva, Switzerland) forward biological response markers show the physics induce similar levels of neopterin. However, Betaferon was associated with three times les injection pain, and half the skin reactions at the injection site, than
Dental Care , Alveo , Skin Care Chat , Schmuck , Asthma Product |